Yıldız, Oğuzhan, Melek Karakurt Eryılmaz, Talat Aykut, Ömer Genç, Bahattin Engin Kaya, and Ali Fuat Gürbüz. “Reduced Efficacy of Nivolumab Following Prior Immunotherapy in Metastatic Renal Cell Carcinoma: Implications for Sequential Immune Checkpoint Inhibition”. EXPERIMENTAL BIOMEDICAL RESEARCH 9, no. 1 (January 1, 2026): 1–9. Accessed January 2, 2026. https://www.experimentalbiomedicalresearch.com/index.php/ebr/article/view/527.